Welcure Drugs & Pharmaceuticals Limited reported unaudited standalone earnings results for the third quarter ended December 31, 2017. For the quarter, the company's total revenue was nil compared to INR 0.234 million a year ago. Loss from operations before exceptional items and tax items was INR 0.026 million compared to profit of INR 0.109 million a year ago. Loss before tax was INR 0.026 million compared to profit of INR 0.109 million a year ago. Loss was INR 0.026 million compared to profit of INR 0.109 million a year ago. Basic and diluted loss per share was INR 0.002 compared to earnings per share of INR 0.001 a year ago.